EUVIMEDEUVIMED entdecken
Open Access

17β‐Estradiol Maintains Mitochondrial Homeostasis in Osteoblasts by Inhibiting MMP ‐8 and Activating the Ras Signaling Pathway in Postmenopausal Osteoporosis

Huan Min, Yuxu Li, Gang Chen, Jiabin Wen, Xi Li, Zhisheng Long, Jinhui Cheng iD

The FASEB Journal · 31.07.2026 · 40 (14)

DOI: 10.1096/fj.202601404r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 22.07.2026. Verfasst von Huan Min und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Osteoblasts, Mitochondria, Matrix Metalloproteinase 8, Signal Transduction. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science and Technology Program of Jiangxi Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

17β‐estradiol is a potent endogenous estrogen used for postmenopausal osteoporosis treatment. Its osteoprotective role correlates with matrix metalloproteinase (MMP) and mitochondrial homeostasis. This research sought to examine the role of 17β‐estradiol on MMP‐8 in mitochondrial homeostasis and elucidate the potential regulatory pathways. We evaluated the effects of 17β‐estradiol on MMP‐8, bone loss, osteogenic differentiation, and mitochondrial homeostasis in bilateral ovariectomy (OVX)‐induced mice and MC3T3‐E1 cells. MMP‐8 was overexpressed to validate its regulatory relationship with 17β‐estradiol. Comprehensive analyses were further conducted to identify the potential pathways associated with MMP‐8. The Ras pathway agonist ML‐099 and inhibitor Lonafarnib were used for pathway validation. 17β‐estradiol treatment attenuated bone loss and increased osteogenic Ca 2+ , osteoprotegerin (OPG), and osteocalcin (OC) levels. It inhibited reactive oxygen species (ROS) and malondialdehyde (MDA), promoted superoxide dismutase (SOD) activity, and restored mitochondrial homeostasis via upregulating the expression of dynamin‐related protein 1 (DRP1), mitofusin 1 (MFN1), and peroxisome proliferator‐activated receptor γ coactivator 1 alpha (PGC‐1α), accompanied by increased adenosine triphosphate (ATP), mitochondrial membrane potential, and mitochondrial oxygen consumption. MMP‐8 overexpression significantly reversed these protective effects. The Ras pathway was identified as a potential pathway associated with MMP‐8‐mediated osteoporosis regulation. ML‐099 administration in 17β‐estradiol + MMP‐8 overexpression cells markedly restored mitochondrial homeostasis and rescued osteogenic differentiation. Conversely, the adverse impacts of MMP‐8 overexpression on osteoblast differentiation, mitochondrial homeostasis, and Ras activation were further aggravated by Lonafarnib treatment. 17β‐estradiol maintains mitochondrial homeostasis in osteoblasts via inhibiting MMP‐8 and activating the Ras pathway, which provides novel potential targets for postmenopausal osteoporosis management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoblastsMitochondriaMatrix Metalloproteinase 8Signal TransductionEstradiolOsteoporosis, Postmenopausalras ProteinsAnimalsFemaleMiceHomeostasisOsteogenesisHumansReactive Oxygen Species

Stichwörter der Autor:innen

17β‐estradiolMMP‐8Ras signaling pathwaymitochondrial homeostasisosteoporosis

Substanzen

Matrix Metalloproteinase 8Estradiolras ProteinsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Orthopedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
  • Department of Ultrasound Imaging, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

ORCID-Profile: Jinhui Cheng

Förderung

  • Science and Technology Program of Jiangxi Provincial Health Commission

Zitieren

APA

Min, H., Li, Y., Chen, G., Wen, J., Li, X., Long, Z., & Cheng, J. (2026). 17β‐Estradiol Maintains Mitochondrial Homeostasis in Osteoblasts by Inhibiting MMP ‐8 and Activating the Ras Signaling Pathway in Postmenopausal Osteoporosis. The FASEB Journal, 40(14). https://doi.org/10.1096/fj.202601404r

Vancouver

Min H, Li Y, Chen G, Wen J, Li X, Long Z, et al. 17β‐Estradiol Maintains Mitochondrial Homeostasis in Osteoblasts by Inhibiting MMP ‐8 and Activating the Ras Signaling Pathway in Postmenopausal Osteoporosis. The FASEB Journal. 2026;40(14). doi:10.1096/fj.202601404r

BibTeX
@article{Min2026,
  author = {Min, Huan and Li, Yuxu and Chen, Gang and Wen, Jiabin and Li, Xi and Long, Zhisheng and Cheng, Jinhui},
  title = {17β‐Estradiol Maintains Mitochondrial Homeostasis in Osteoblasts by Inhibiting MMP ‐8 and Activating the Ras Signaling Pathway in Postmenopausal Osteoporosis},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {14},
  doi = {10.1096/fj.202601404r}
}
Kostenlos starten →